Greg Giles has struggled with debilitating eczema for most of his life, relying on the injectable treatment Dupixent for relief. Nearly 20,000 Australians have turned to the medication since it was included in the Pharmaceutical Benefit Scheme in 2021, with its effectiveness and minimal side effects making it a popular choice. Despite concerns of being pulled from the PBS due to costs, a new deal has been secured to ensure continued access to the treatment, providing relief for patients and reducing healthcare expenses.
Full Article
New device to help treat serious birth risk for women
Women experiencing postpartum haemorrhages, which affect 5-15% of new mothers, may soon have more treatment options with the addition of the JADA device to Australia’s therapeutic goods register. This device uses low-level vacuum to induce uterine contractions, potentially improving outcomes for those facing this serious condition that can lead to significant physical and psychological impacts. Want More Context? 🔎
Read more